10:08:24 EDT Tue 01 Jul 2025
Enter Symbol
or Name
USA
CA



Diagnos Inc (3)
Symbol ADK
Shares Issued 101,862,977
Close 2025-06-10 C$ 0.20
Market Cap C$ 20,372,595
Recent Sedar Documents

Diagnos appoints Weiner to advisory board

2025-06-10 18:18 ET - News Release

Mr. Andre Larente reports

DIAGNOS WELCOMES FOUNDER OF NATIONAL VISION ASSOCIATES, ED WEINER, TO ITS ADVISORY BOARD FOR THE UNITED STATES

Ed Weiner has joined Diagnos Inc.'s advisory board.

Mr. Weiner will team up with Dr. Tomas J. Philipson, former vice-chairman and acting chairman of the White House Council of Economic Advisers, to provide valuable insights to Diagnos about the United States optical market. Mr. Weiner is a seasoned entrepreneur and has been a leader in the optical industry for decades. He was the first to introduce Ralph Lauren Eyewear. He also partnered with Walmart to open 400 optical locations within Walmart's chain of stores. Mr. Weiner was also chairman and founder of National Vision Associates, one of the largest optical retailers in the United States.

"We are honoured to welcome Ed to our advisory board," said Andre Larente, president and chief executive officer of Diagnos. "In our opinion, his deep knowledge of the U.S. optical market will contribute to bring Diagnos as one of the main AI driven health care solutions among opticians and optometrists across the U.S."

Mr. Larente added: "Diagnos has built an AI platform to analyze retina images, these images are taken by thousands of optometrists worldwide. According to recent VisionWatch data, the U.S. saw approximately 111 million routine eye exams and 60 million medical eye exams in 2020. Diagnos, along with its partners, can address this growing market." Diagnos recently opened its United States office in south Florida to support its U.S. prospects and clients.

About Diagnos Inc.

Diagnos is a publicly traded Canadian corporation dedicated to early detection of critical eye-related health problems. By leveraging artificial intelligence, Diagnos aims to provide more information to health care clinicians to enhance diagnostic accuracy, streamline workflows and improve patient outcomes on a global scale.

We seek Safe Harbor.

© 2025 Canjex Publishing Ltd. All rights reserved.